Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Iron bisglycinate

Ferrous Bisglycinate Chelate (Ferrochel) · also known as Chelated iron, Weak acid iron, Ferrous bisglycinate, Ferrochel

Iron bisglycinate is an iron supplement in organic chelated form. A systematic review showed it can improve hemoglobin in some groups. It cannot be guaranteed to avoid gastrointestinal side effects completely, and proposed mechanisms such as mitochondrial effects and antibacterial action in the mucosa lack direct human evidence.

Typical dose: Elemental iron 20–45 mg/day, depending on anemia status or ferritin stores, taken with a meal
Absorption and forms: Absorption is usually higher than with ferrous sulfate, but it cannot be claimed to be consistently 3–4 times higher. Components such as phytates and polyphenols may affect absorption. Gastrointestinal side effects cannot be guaranteed to be avoided completely either.

Clinical uses and human evidence

Iron deficiency and iron-deficiency anemia

BeneficialGrade A · Strong evidence
Studies (3)
  1. Fischer 2023 · Nutr Rev · Meta-analysis — The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials
  2. Pineda 2001 · Nutrition · RCT · n=40 — Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate
  3. Milman 2014 · J Perinat Med · RCT · n=80 — Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial

All-cause mortality risk

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Song 2022 · ESC Heart Fail · Meta-analysis · n=590 — Oral iron supplementation in patients with heart failure: a systematic review and meta-analysis
  2. Chen 2019 · Ann Intern Med · Cohort study · n=30899 — Association Among Dietary Supplement Use, Nutrient Intake, and Mortality Among U.S. Adults: A Cohort Study

Falls in older adults

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. He 2022 · Front Nutr · Cohort study · n=30630 — Association of vitamin and/or nutritional supplements with fall among patients with diabetes: A prospective study based on ACCORD and UK Biobank

Mechanisms of action

Mitochondrial electron transport chain carriers and oxidative phosphorylation coupling

★★★☆☆Mechanism evidence: grade C

Iron is a component of iron-sulfur clusters and heme, and iron deficiency impairs iron-containing respiratory chain proteins. In rats, iron deficiency lowered succinate dehydrogenase activity in muscle, and activity recovered after iron injection. Human studies have observed improved hemoglobin in some groups, but effects on the mitochondrial electron transport chain have not been measured directly.

References (2)
  1. McKay 1983 · Rat iron deficiency and repletion study: iron deficiency lowered muscle succinate dehydrogenase activity, which recovered after iron injection.
  2. Fischer 2023 · Systematic review of RCTs: ferrous bisglycinate improved hemoglobin in some groups, but its effect on the mitochondrial electron transport chain was not directly measured.

Safety and drug interactions

People without a confirmed iron deficiency must not take large doses long-term without good reason. Hereditary hemochromatosis is an absolute contraindication. Serum ferritin must be monitored regularly. Iron can reduce the absorption of levothyroxine, tetracyclines and quinolones, so when taking them together, separate the doses as the drug label directs.

With Antihypertensive drugs Needs attention

Amlodipine, valsartan, benazepril, metoprolol, hydrochlorothiazide

Iron markedly reduces methyldopa absorption, which can worsen blood pressure control. People taking methyldopa should separate the two by at least 2 hours and monitor their blood pressure (methyldopa only).

With Levothyroxine Needs attention

Euthyrox, Letrox (levothyroxine)

Iron markedly reduces levothyroxine absorption, so take the two at least 4 hours apart. If the timing changes, recheck thyroid function 6–8 weeks later.

With Levodopa Needs attention

Levodopa/benserazide (Madopar), carbidopa/levodopa (Sinemet)

Iron reduces levodopa absorption and may worsen motor symptoms. Separate the doses as much as possible and watch for changes in symptoms.

With Acid suppressants (long-term use) Needs attention

Proton pump inhibitors such as omeprazole, rabeprazole and esomeprazole; famotidine

Long-term acid suppression may make oral iron less effective, and simply spacing the doses apart does not necessarily solve this. During iron supplementation, recheck hemoglobin and ferritin to see whether it is working.

Related lab tests

Ferritin and iron panel Test before supplementing

Iron supplements give no benefit if you are not iron deficient, and long-term excess may also harm the liver and other organs. Before taking iron, confirm iron deficiency and find its cause (such as heavy menstrual bleeding or gastrointestinal bleeding).

Ferritin and iron panel Recheck while taking

Recheck ferritin about 3 months after starting iron to see whether stores have recovered. People with anemia should recheck hemoglobin sooner.

Ferritin and iron panel Can distort results

Recent iron supplements temporarily raise serum iron and transferrin saturation. Do not take iron for 24 hours before the blood draw.

Open in the interactive app ›